Melanoma-associated chondroitin sulfate proteoglycan: A promising target antigen for cancer immunotherapy?

C. Erfurt, I. Haendle, Eckhart Kämpgen, Kris Thielemans, Pierre Van Der Bruggen, Gerold Schuler, Erwin Schultz

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)219-219
Number of pages1
JournalExperimental Dermatology
Issue number3
Publication statusPublished - Mar 2006


  • melanoma
  • cancer immunotherapy
  • chondroitin
  • proteoglycan

Cite this